Simultaneous Determination of Steroids and Glucocorticoids in Human Urine by Ultra-High-Performance Liquid Chromatography – Tandem Mass Spectrometry (UPLC–MS/MS)

References

• Arai, S., Y. Miyashiro, Y. Shibata, B. Kashiwagi, Y. Tomaru, M. Kobayashi, Y. Watanabe, S. Honma, and K. Suzuki. 2010. New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry. Steroids 75 (1):13–9. doi:10.1016/j.steroids.2009.09.004.
   PubMed Web of Science ®Google Scholar
• Cho, S.-H., S.-K. Lee, and C. H. Kim. 2018. The determination of polycyclic aromatic hydrocarbons in human urine by high-resolution gas chromatography-mass spectrometry. Biomedical Chromatography : BMC 32 (5):e4166. doi:10.1002/bmc.4166.
   PubMed Web of Science ®Google Scholar
• Chu, L. X., Y. Huang, Y. H. Xu, L. K. Wang, and Q. Lu. 2021. An LC-APCI plus -MS/MS-based method for determining the concentration of neurosteroids in the brain of male mice with different gut microbiota. Journal of Neuroscience Methods 360:109268. doi:10.1016/j.jneumeth.2021.109268.
   PubMed Web of Science ®Google Scholar
• Chu, L., N. Li, J. Deng, Y. Wu, H. Yang, W. Wang, D. Zhou, and H. Deng. 2020. LC-APCI+-MS/MS method for the analysis of ten hormones and two endocannabinoids in plasma and hair from the mice with different gut microbiota. Journal of Pharmaceutical and Biomedical Analysis 185:113223. doi:10.1016/j.jpba.2020.113223.
   PubMed Web of Science ®Google Scholar
• Chu, L., W. Liu, J. Deng, Y. Wu, H. Yang, W. Wang, A. Hussain, N. Li, D. Zhou, and H. Deng. 2021. Age-related changes in endogenous glucocorticoids, gonadal steroids, endocannabinoids and their ratios in plasma and hair from the male C57BL/6 mice. General and Comparative Endocrinology 301 (113651):113651. doi:10.1016/j.ygcen.2020.113651.
   PubMed Web of Science ®Google Scholar
• Chu, L., L. K. Wang, Y. Wu, H. Yang, W. Wang, Q. Lu, and H. Deng. 2022. Plasma steroids and endocannabinoids used as biomarkers to assess the pruritus severity of patients with prurigo nodularis. Actas Dermo-Sifiliograficas 113 (3):244–53. doi:10.1016/j.ad.2022.02.016.
   PubMed Web of Science ®Google Scholar
• Chu, L. X., Y. Wu, L. L. Yang, H. R. Yang, Q. Lu, and H. H. Deng. 2021. Abnormal levels of cortisol and cortisone in patients with prurigo nodularis. Indian Journal of Dermatology 66 (6):685–7. doi:10.4103/ijd.IJD_912_20.
   PubMed Web of Science ®Google Scholar
• Clos-Garcia, M., A. Loizaga-Iriarte, P. Zuñiga-Garcia, P. Sánchez-Mosquera, A. R. Cortazar, E. González, V. Torrano, C. Alonso, M. Pérez-Cormenzana, A. Ugalde-Olano, et al. 2018. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression. Journal of Extracellular Vesicles 7 (1):1470442. doi:10.1080/20013078.2018.1470442.
   PubMed Web of Science ®Google Scholar
• Cook, M. B., F. Z. Stanczyk, S. N. Wood, R. M. Pfeiffer, M. Hafi, C. C. Veneroso, B. Lynch, R. T. Falk, C. K. Zhou, S. Niwa, et al. 2017. Relationships between circulating and intraprostatic sex steroid hormone concentrations. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26 (11):1660–6. doi:10.1158/1055-9965.EPI-17-0215.
   PubMed Web of Science ®Google Scholar
• De Luca, S., E. Amante, C. Fiori, G. Alleva, E. Alladio, F. Marini, D. Garrou, M. Manfredi, D. Amparore, E. Checcucci, et al. 2021. Prospective evaluation of urinary steroids and prostate carcinoma-induced deviation: Preliminary results. Minerva Urology and Nephrology 73 (1):98–106.
   PubMed Web of Science ®Google Scholar
• Dean, M., B. T. Murphy, and J. E. Burdette. 2017. Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products. Molecular and Cellular Endocrinology 442 (C):98–105. doi:10.1016/j.mce.2016.12.013.
   PubMed Web of Science ®Google Scholar
• Escobar-Wilches, D. C., A. Ventura-Bahena, M. d L. López-González, L. Torres-Sánchez, M. Figueroa, and A. Sierra-Santoyo. 2020. Analysis of testosterone-hydroxylated metabolites in human urine by ultra high performance liquid chromatography-mass spectrometry. Analytical Biochemistry 597:113670. doi:10.1016/j.ab.2020.113670.
   PubMed Web of Science ®Google Scholar
• Ferraldeschi, R., N. Sharifi, R. J. Auchus, and G. Attard. 2013. Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 19 (13):3353–9. doi:10.1158/1078-0432.CCR-12-0931.
   PubMed Web of Science ®Google Scholar
• Jemal, A., S. A. Fedewa, J. M. Ma, R. Siegel, C. C. Lin, O. Brawley, and E. M. Ward. 2015. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. Jama 314 (19):2054–61. doi:10.1001/jama.2015.14905.
   PubMed Web of Science ®Google Scholar
• Kux, L. 2012. Draft guidance for industry and food and drug administration staff; acceptance and filing review for premarket approval applications. Federal Register.
   Google Scholar
• Lu, D., J. A. Sinnott, U. Valdimarsdóttir, F. Fang, T. Gerke, S. Tyekucheva, M. Fiorentino, M. Lambe, H. D. Sesso, C. J. Sweeney, et al. 2016. Stress-related signaling pathways in lethal and nonlethal prostate cancer. Clinical Cancer Research 22 (3):765–72. doi:10.1158/1078-0432.CCR-15-0101.
   PubMed Web of Science ®Google Scholar
• Lucarelli, G., D. Loizzo, M. Ferro, M. Rutigliano, M. D. Vartolomei, F. Cantiello, C. Buonerba, G. Di Lorenzo, D. Terracciano, O. De Cobelli, et al. 2019. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: An update. Expert Review of Molecular Diagnostics 19 (5):377–87. doi:10.1080/14737159.2019.1604223.
   PubMed Web of Science ®Google Scholar
• Lutgendorf, S. K., and A. K. Sood. 2011. Biobehavioral factors and cancer progression: Physiological pathways and mechanisms. Psychosomatic Medicine 73 (9):724–30. doi:10.1097/PSY.0b013e318235be76.
   PubMed Web of Science ®Google Scholar
• Marker, P. C., A. A. Donjacour, R. Dahiya, and G. R. Cunha. 2003. Hormonal, cellular, and molecular control of prostatic development. Developmental Biology 253 (2):165–74. doi:10.1016/S0012-1606(02)00031-3.
   PubMed Web of Science ®Google Scholar
• Platz, E. A., M. F. Leitzmann, N. Rifai, P. W. Kantoff, Y. C. Chen, M. J. Stampfer, W. C. Willett, and E. Giovannucci. 2005. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiology, Biomarkers & Prevention 14 (5):1262–9. doi:10.1158/1055-9965.EPI-04-0371.
   PubMed Web of Science ®Google Scholar
• Prins, G. S., and K. S. Korach. 2008. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 (3):233–44. doi:10.1016/j.steroids.2007.10.013.
   PubMed Web of Science ®Google Scholar
• Roddam, A. W., N. E. Allen, P. Appleby, and T. J. Key. 2008. Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. Journal of the National Cancer Institute 100 (3):170–83. doi:10.1093/jnci/djm323.
   PubMedGoogle Scholar
• Rodrigues, D. N., G. Boysen, S. Sumanasuriya, G. Seed, A. M. De Marzo, and J. de Bono. 2017. The molecular underpinnings of prostate cancer: Impacts on management and pathology practice. The Journal of Pathology 241 (2):173–82. doi:10.1002/path.4826.
   PubMed Web of Science ®Google Scholar
• Schiffer, L., L. Barnard, E. S. Baranowski, L. C. Gilligan, A. E. Taylor, W. Arlt, C. H. L. Shackleton, and K. H. Storbeck. 2019. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review. The Journal of Steroid Biochemistry and Molecular Biology 194:105439.
   PubMed Web of Science ®Google Scholar
• Shaneyfelt, T., R. Husein, G. Bubley, and C. S. Mantzoros. 2000. Hormonal predictors of prostate cancer: A meta-analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 18 (4):847–53. doi:10.1200/JCO.2000.18.4.847.
   PubMed Web of Science ®Google Scholar
• Smith, G. 2012. European Medicines Agency (EMA). Guideline on bioanalytical method validation, 21 July 2011. Bioanalysis 4 (8):865–8. doi:10.4155/bio.12.44.
   PubMed Web of Science ®Google Scholar
• Son, H. H., W. S. Yun, and S.-H. Cho. 2020. Development and validation of an LC‐MS/MS method for profiling 39 urinary steroids (estrogens, androgens, corticoids, and progestins). Biomedical Chromatography : BMC 34 (2):e4723. doi:10.1002/bmc.4723.
   PubMed Web of Science ®Google Scholar
• Sonpavde, G. 2011. Abiraterone and increased survival in metastatic prostate cancer. The New England Journal of Medicine 365 (8):766–7. doi:10.1056/NEJMc1107198.
   PubMed Web of Science ®Google Scholar
• Ventura-Bahena, A., J. G. Hernández-Pérez, L. Torres-Sánchez, A. Sierra-Santoyo, D. Constanza Escobar-Wilches, C. Escamilla-Núñez, R. Gómez, F. Rodríguez-Covarrubias, M. d L. López-González, and M. Figueroa. 2021. Urinary androgens excretion patterns and prostate cancer in Mexican men. Endocrine-Related Cancer 28 (12):745–56. doi:10.1530/ERC-21-0160.
   PubMed Web of Science ®Google Scholar